You just read:

Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients

News provided by

Nile Therapeutics, Inc.

Oct 18, 2011, 07:30 ET